Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Current Leases (2019 - 2025)

Catheter Precision (VTAK) has disclosed Current Leases for 7 consecutive years, with $86000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Current Leases fell 10.42% to $86000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $86000.0, a 10.42% decrease, with the full-year FY2024 number at $98000.0, up 7.69% from a year prior.
  • Current Leases was $86000.0 for Q2 2025 at Catheter Precision, up from $83000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $338000.0 in Q1 2021 to a low of $51000.0 in Q1 2023.
  • A 5-year average of $169562.5 and a median of $97000.0 in 2024 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: tumbled 82.47% in 2023, then skyrocketed 82.35% in 2024.
  • Catheter Precision's Current Leases stood at $283000.0 in 2021, then rose by 8.83% to $308000.0 in 2022, then plummeted by 70.45% to $91000.0 in 2023, then rose by 7.69% to $98000.0 in 2024, then decreased by 12.24% to $86000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Current Leases are $86000.0 (Q2 2025), $83000.0 (Q1 2025), and $98000.0 (Q4 2024).